Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Hironori, Yamasaki"'
Publikováno v:
RMD Open, Vol 10, Iss 3 (2024)
Objectives This study aimed to evaluate the long-term safety and efficacy profiles of ozoralizumab in patients with rheumatoid arthritis (RA) from the OHZORA, NATSUZORA and HOSHIZORA trials.Methods This study conducted an integrated analysis of the t
Externí odkaz:
https://doaj.org/article/fcfd4e7e78c342cca973a8b09b70b145
Publikováno v:
RMD Open; Jul2024, Vol. 10 Issue 3, p1-10, 10p
Publikováno v:
Modern Rheumatology; Jul2024, Vol. 34 Issue 4, p678-685, 8p
Publikováno v:
Arthritis & Rheumatology. 74:1776-1785
To assess the efficacy and safety of subcutaneous administration of 30 mg or 80 mg of ozoralizumab plus methotrexate (MTX) in patients with rheumatoid arthritis (RA) whose disease remained active despite MTX therapy.In this multicenter, double-blind,
Autor:
Hideyuki Kinoshita, Masayuki Hashimoto, Jiro Hirayama, Kouji Fujita, Yoshio Takeuchi, Junichi Iwasaki, Hironori Yamasaki, Mitsuhiro Kitamura, Seiji Ohtori, Tsuguo Morikawa
Publikováno v:
Case Reports in Orthopedics, Vol 2018 (2018)
Pseudoaneurysm is one of the most serious complications of femoral trochanteric fracture surgery. Since the rupture of pseudoaneurysm may lead to death, early detection is important. We report the case of an 80-year-old male who developed pain in the
Externí odkaz:
https://doaj.org/article/ffc3c35f5fb7405da5f1415d83819d3c
Publikováno v:
Modern rheumatology.
Objective To assess the efficacy and safety through a 52-week treatment with subcutaneous ozoralizumab at 30 or 80 mg in patients with active rheumatoid arthritis despite methotrexate therapy. Methods This multicentre, randomized, placebo-controlled,
Autor:
Atsushi Takeoka, Jun Tayama, Hironori Yamasaki, Masakazu Kobayashi, Sayaka Ogawa, Tatsuo Saigo, Masaki Hayashida, Susumu Shirabe
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166588 (2016)
BACKGROUND:Helicobacter pylori (HP) infection is implicated in gastric and extra-gastric diseases. While gastritis-related chronic inflammation represents a known trigger of metabolic disturbances, whether metabolic syndrome (MetS) is affected by gas
Externí odkaz:
https://doaj.org/article/a4b9e14760084c48acf776286fee171d
Publikováno v:
Hypertension Research. 43:876-883
Acute decline in estimated glomerular filtration rate (eGFR), a typical finding after initiating sodium-glucose cotransporter 2 (SGLT2) inhibitors, is associated with maintaining renal function in type 2 diabetes. However, the relationship between th
Autor:
Ai Haraguchi, Naomi Hayashida, Toshihiko Kamasaki, Izumi Miyamoto, Toshiya Usui, Takao Ando, Norio Abiru, Hironori Yamasaki, Kenya Chiba, Takashi Kudo, Atsushi Kawakami, Noboru Takamura
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e111990 (2014)
OBJECTIVE: This study investigated the relationship between aortic 18F-fluoro-2-deoxy-D-glucose (18F-FDG) uptake and clinical and laboratory findings related to atherosclerosis in a general population. METHODS: 18F-FDG uptake in the ascending aorta w
Externí odkaz:
https://doaj.org/article/e9cb5a9ab42e4aafb738f204ab096520
Autor:
Fumiaki Nonaka, Shiro Hata, Keisuke Iwasaki, Haruna Matsuo, Yasumasa Taniguchi, Hironori Yamasaki, Keita Nakaji, Saburo Kusumoto
Publikováno v:
Nihon Naika Gakkai Zasshi. 107:1543-1550